A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells.

about

A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells.

Item

http://www.wikidata.org/entity/Q55075584

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

A novel oncolytic herpes simpl ...... nst human breast cancer cells.

@en

A novel oncolytic herpes simpl ...... nst human breast cancer cells.

@nl

type

Item

label

A novel oncolytic herpes simpl ...... nst human breast cancer cells.

@en

A novel oncolytic herpes simpl ...... nst human breast cancer cells.

@nl

prefLabel

A novel oncolytic herpes simpl ...... nst human breast cancer cells.

@en

A novel oncolytic herpes simpl ...... nst human breast cancer cells.

@nl

P1476

A novel oncolytic herpes simpl ...... nst human breast cancer cells.

@en

P2093

Hua Jiang

http://www.w3.org/2001/XMLSchema#string

Jiani Wang

http://www.w3.org/2001/XMLSchema#string

Jingjing Fan

http://www.w3.org/2001/XMLSchema#string

Lin Cheng

http://www.w3.org/2001/XMLSchema#string

Pan Hu

http://www.w3.org/2001/XMLSchema#string

Renbin Liu

http://www.w3.org/2001/XMLSchema#string

Ying Ruan

http://www.w3.org/2001/XMLSchema#string

P2860

Retargeting Strategies for Oncolytic Herpes Simplex Viruses

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.

Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2

Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2.

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1

The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells.

Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors.

P304

7046-7052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8247

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29849789

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5962873

http://www.w3.org/2001/XMLSchema#string